McGowan IM - Search Results

1

A Randomized, Open-Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study).

McGowan IM, Chawki S, Hendrix CW, Anton PA, Marzinke MA, Brand RM, Engstrom JC, Rohan LC, Abebe KZ, Richardson-Harman N, Siegel A, Reinhart A, Steytler J, Stall R, Spiegel H, Chen B, Achilles SL, Jacobson CE, Khanukova E, Cranston RD. McGowan IM, et al. AIDS Res Hum Retroviruses. 2022 Apr;38(4):269-278. doi: 10.1089/AID.2021.0096. Epub 2021 Sep 14. AIDS Res Hum Retroviruses. 2022. PMID: 34384282 Free PMC article. Clinical Trial.

2

Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa.

Gurney KB, Elliott J, Nassanian H, Song C, Soilleux E, McGowan I, Anton PA, Lee B. Gurney KB, et al. J Virol. 2005 May;79(9):5762-73. doi: 10.1128/JVI.79.9.5762-5773.2005. J Virol. 2005. PMID: 15827191 Free PMC article.

3

Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides.

Fletcher PS, Elliott J, Grivel JC, Margolis L, Anton P, McGowan I, Shattock RJ. Fletcher PS, et al. AIDS. 2006 Jun 12;20(9):1237-45. doi: 10.1097/01.aids.0000232230.96134.80. AIDS. 2006. PMID: 16816551

4

Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals.

Poles MA, Boscardin WJ, Elliott J, Taing P, Fuerst MM, McGowan I, Brown S, Anton PA. Poles MA, et al. J Acquir Immune Defic Syndr. 2006 Sep;43(1):65-8. doi: 10.1097/01.qai.0000230524.71717.14. J Acquir Immune Defic Syndr. 2006. PMID: 16936559

5

HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.

Grivel JC, Elliott J, Lisco A, Biancotto A, Condack C, Shattock RJ, McGowan I, Margolis L, Anton P. Grivel JC, et al. AIDS. 2007 Jun 19;21(10):1263-72. doi: 10.1097/QAD.0b013e3281864667. AIDS. 2007. PMID: 17545702

6

Characterization of baseline intestinal mucosal indices of injury and inflammation in men for use in rectal microbicide trials (HIV Prevention Trials Network-056).

McGowan I, Elliott J, Cortina G, Tanner K, Siboliban C, Adler A, Cho D, Boscardin WJ, Soto-Torres L, Anton PA. McGowan I, et al. J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):417-25. doi: 10.1097/QAI.0b013e318156ef16. J Acquir Immune Defic Syndr. 2007. PMID: 17891044

7

Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.

Cranage M, Sharpe S, Herrera C, Cope A, Dennis M, Berry N, Ham C, Heeney J, Rezk N, Kashuba A, Anton P, McGowan I, Shattock R. Cranage M, et al. PLoS Med. 2008 Aug 5;5(8):e157; discussion e157. doi: 10.1371/journal.pmed.0050157. PLoS Med. 2008. PMID: 18684007 Free PMC article.

8

Reverse transcriptase inhibitors as potential colorectal microbicides.

Herrera C, Cranage M, McGowan I, Anton P, Shattock RJ. Herrera C, et al. Antimicrob Agents Chemother. 2009 May;53(5):1797-807. doi: 10.1128/AAC.01096-08. Epub 2009 Mar 2. Antimicrob Agents Chemother. 2009. PMID: 19258271 Free PMC article.

9

Rectal microbicides.

McGowan I, Anton P. McGowan I, et al. Curr Opin HIV AIDS. 2008 Sep;3(5):593-8. doi: 10.1097/COH.0b013e32830891cf. Curr Opin HIV AIDS. 2008. PMID: 19373027

10

Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men.

Ventuneac A, Carballo-Diéguez A, McGowan I, Dennis R, Adler A, Khanukhova E, Price C, Saunders T, Siboliban C, Anton P. Ventuneac A, et al. AIDS Behav. 2010 Jun;14(3):618-28. doi: 10.1007/s10461-009-9611-5. Epub 2009 Sep 11. AIDS Behav. 2010. PMID: 19757017 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters